Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sonrotoclax, Zanubrutinib and Rituximab in Previously Untreated Follicular Lymphoma
NCT07550855Phase 2Not yet recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Sep 2026
- Primary completion
- Mar 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of sonrotoclax in follicular lymphoma (FL), sponsored by Sun Yat-sen University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
sonrotoclax
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT07550855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07550855.